home / stock / tela / tela news

TELA News and Press, TELA Bio Inc. From 06/22/20

Stock Information
Company Name: TELA Bio Inc.
Stock Symbol: TELA
Market: NYSE
Website: telabio.com
Menu
TELA TELA Quote TELA Short TELA News TELA Articles TELA Message Board
Get TELA Alerts

News, Short Squeeze, Breakout and More Instantly...
TELA - TELA Bio, Inc. to Join the Russell 2000® Index

MALVERN, Pa., June 22, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today a...
TELA - TELA Bio, Inc. Announces Poster Presentations at the 2020 Minimally Invasive Surgery Symposium (MISS)

MALVERN, Pa., June 15, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today a...

TELA - TELA Bio to Present at the Jefferies Virtual Healthcare Conference

MALVERN, Pa., May 29, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today an...

TELA - TELA Bio, Inc. (TELA) CEO Antony Koblish on Q1 2020 Results - Earnings Call Transcript

TELA Bio, Inc. (TELA) Q1 2020 Earnings Conference Call May 12, 2020, 04:30 PM ET Company Participants Stuart Henderson - VP, Corporate Development and Investor Relations Antony Koblish - President and CEO Nora Brennan - CFO Conference Call Participants Raj Denhoy - Jefferie...
TELA - TELA Bio EPS misses by $0.06, beats on revenue

TELA Bio (NASDAQ: TELA ): Q1 GAAP EPS of -$0.63 misses by $0.06 . More news on: TELA Bio, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

TELA - TELA Bio Announces First Quarter 2020 Financial Results

MALVERN, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today re...

TELA - U.S. IPO Week Ahead: GAN Bets On Itself In A One-IPO Week

Just one IPO is scheduled for the week ahead, though there are a handful of deals in the IPO pipeline that are primed for May public offerings. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after upsizing its deal...
TELA - TELA Bio to Announce First Quarter 2020 Financial Results and Host Conference Call on May 12, 2020

MALVERN, Pa., April 28, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, an...

TELA - TELA Bio Announces Changes to its Board of Directors

MALVERN, Pa., April 23, 2020 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, to...

TELA - TELA Bio, Inc. (TELA) CEO Antony Koblish on Q4 2019 Results - Earnings Call Transcript

TELA Bio, Inc.. (TELA) Q4 2019 Earnings Conference Call March 27, 2020 08:00 AM ET Company Participants Stuart Henderson - Vice President, Corporate Development and Investor Relations Antony Koblish - Co-founder, President, Chief Executive Officer Nora Brennan - Chief Financial O...
Previous 10 Next 10